Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21164387rdf:typepubmed:Citationlld:pubmed
pubmed-article:21164387lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:21164387lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:21164387lifeskim:mentionsumls-concept:C0305065lld:lifeskim
pubmed-article:21164387lifeskim:mentionsumls-concept:C0206515lld:lifeskim
pubmed-article:21164387lifeskim:mentionsumls-concept:C0681698lld:lifeskim
pubmed-article:21164387lifeskim:mentionsumls-concept:C0205281lld:lifeskim
pubmed-article:21164387lifeskim:mentionsumls-concept:C1414461lld:lifeskim
pubmed-article:21164387lifeskim:mentionsumls-concept:C0348080lld:lifeskim
pubmed-article:21164387pubmed:issue3lld:pubmed
pubmed-article:21164387pubmed:dateCreated2011-2-14lld:pubmed
pubmed-article:21164387pubmed:abstractTextWe analyzed characteristics of invasive pneumococcal disease cases occurring in Massachusetts after the introduction and use of conjugate vaccine by underlying risk. Among 578 cases with sufficient information, 16% had high-risk or presumed high-risk conditions (HR/PHR), 3% had asthma, and 80% had no known risk (NKR). The most common HR/PHR conditions were disorders associated with immunosuppression. HR/PHR cases tended to be older and were more likely to be hospitalized than were children with NKR. Children with asthma presented with pneumonia more often than children with NKR.lld:pubmed
pubmed-article:21164387pubmed:languageenglld:pubmed
pubmed-article:21164387pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21164387pubmed:citationSubsetIMlld:pubmed
pubmed-article:21164387pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21164387pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21164387pubmed:statusMEDLINElld:pubmed
pubmed-article:21164387pubmed:monthMarlld:pubmed
pubmed-article:21164387pubmed:issn1532-0987lld:pubmed
pubmed-article:21164387pubmed:authorpubmed-author:PeltonStephen...lld:pubmed
pubmed-article:21164387pubmed:authorpubmed-author:HsuKatherine...lld:pubmed
pubmed-article:21164387pubmed:authorpubmed-author:SheaKimberly...lld:pubmed
pubmed-article:21164387pubmed:authorpubmed-author:StevensonAbbi...lld:pubmed
pubmed-article:21164387pubmed:authorpubmed-author:Members of...lld:pubmed
pubmed-article:21164387pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21164387pubmed:volume30lld:pubmed
pubmed-article:21164387pubmed:ownerNLMlld:pubmed
pubmed-article:21164387pubmed:authorsCompleteYlld:pubmed
pubmed-article:21164387pubmed:pagination251-3lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:meshHeadingpubmed-meshheading:21164387...lld:pubmed
pubmed-article:21164387pubmed:year2011lld:pubmed
pubmed-article:21164387pubmed:articleTitleUnderlying conditions in children with invasive pneumococcal disease in the conjugate vaccine era.lld:pubmed
pubmed-article:21164387pubmed:affiliationSection of Pediatric Infectious Diseases, Boston University School of Public Health, Boston University Medical Center, Boston, MA, USA.lld:pubmed
pubmed-article:21164387pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21164387pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed